Authors:
MONEK O
PAINTAUD G
BECHTEL Y
MIGUET JP
MANTION G
BECHTEL PR
Citation: O. Monek et al., INFLUENCE OF DONOR AND RECIPIENT GENOTYPES ON CYP2D6 PHENOTYPE AFTER LIVER-TRANSPLANTATION - A STUDY OF MUTATIONS CYP2D6(ASTERISK)3 AND CYP2D6(ASTERISK)4, European Journal of Clinical Pharmacology, 54(1), 1998, pp. 47-52
Authors:
BENDRISS EK
BECHTEL Y
BENDRISS A
HUMBERT P
PAINTAUD G
MAGNETTE J
AGACHE P
BECHTEL PR
Citation: Ek. Bendriss et al., INHIBITION OF CAFFEINE METABOLISM BY 5-METHOXYPSORALEN IN PATIENTS WITH PSORIASIS, British journal of clinical pharmacology, 41(5), 1996, pp. 421-424
Authors:
SERREDEBEAUVAIS F
BAYLE F
AMIROU M
BECHTEL Y
BOUJET C
VIALTEL P
BESSARD G
Citation: F. Serredebeauvais et al., AZATHIOPRINE HAEMATOTOXICITY DUE TO LOW T HIOPURINE METHYLTRANSFERASEACTIVITY AND XANTHINE-OXIDASE DEFICIENCY IN A RENAL-TRANSPLANTATION PATIENT, La Presse medicale, 24(21), 1995, pp. 987-988
Authors:
BENDRISS A
BECHTEL Y
PAINTAUD G
BENDRISS EK
JOANNE C
BRESSONHADNI S
MAGNETTE J
BECKER MC
GILLET M
MANTION G
MIGUET JP
BECHTEL PR
Citation: A. Bendriss et al., STABILITY OF DEBRISOQUINE (CYP2D6) PHENOTYPE IN LIVER-TRANSPLANT PATIENTS, Therapeutic drug monitoring, 17(2), 1995, pp. 113-119
Authors:
CHAMBINREMOUSSENARD O
TREFFEL P
BECHTEL Y
AGACHE P
Citation: O. Chambinremoussenard et al., SURFACE RECOVERY AND STRIPPING METHODS TO QUANTIFY PERCUTANEOUS-ABSORPTION OF CAFFEINE IN HUMANS, Journal of pharmaceutical sciences, 82(11), 1993, pp. 1099-1101